Linked Life Data

12451008

Source:http://linkedlifedata.com/resource/pubmed/id/12451008

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2002-11-26
pubmed:abstractText
The high mortality rate in end-stage renal disease has engendered interest in nontraditional atherosclerotic cardiovascular disease (ASCVD) risk factors that are more prevalent in end-stage renal disease, such as elevated lipoprotein(a) [Lp(a)] levels. Previous studies suggest that high Lp(a) levels and small apolipoprotein(a) [apo(a)] isoform size are associated with ASCVD, but none have investigated the relationship between Lp(a) level, apo(a) size, and mortality.
pubmed:grant
pubmed:language
eng
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:author
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2812-8
pubmed:dateRevised
2007-11-14
pubmed:articleTitle
Small apolipoprotein(a) size predicts mortality in end-stage renal disease: The CHOICE study.
pubmed:affiliation
Johns Hopkins University, Baltimore, Md 21205, USA. jlongene@jhsph.edu